
|Articles|December 1, 2003
FDA trial for toric ICL addresses myopic astigmatism
Cincinnati, OH-Early results from an FDA clinical trial suggest that the toric implantable contact lens (ICL, STAAR Surgical) is extremely promising as a safe and effective alternative to LASIK for the correction of myopia with astigmatism, reported David Schneider, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
4DMT releases positive interim 1.5- to 3.5-year data from phase 1/2 PRISM trial
2
Study identifies 6 key genes linking air pollution to dry eye disease
3
Q&A: Karolinne M. Rocha discusses the IOL and patient tolerance of residual astigmatism
4
Avisi Technologies releases positive 12-month data from VITA Trial
5


















































.png)


